Structure, function and regulation of the melanocortin receptors

被引:95
作者
Yang, Yingkui [1 ]
机构
[1] Univ Alabama, Dept Surg, Birmingham, AL 35294 USA
关键词
Orthosteric binding; Allosteric binding; Melanocortin receptor; GPCR; MOLECULAR DETERMINANTS; LIGAND-BINDING; STIMULATING HORMONE; PROTEIN-BINDING; CLONING; SYSTEM; ANTAGONIST; AGONISTS; ACTIVATION; IDENTIFICATION;
D O I
10.1016/j.ejphar.2010.12.020
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Melanocortin receptors belong to the seven-transmembrane (TM) domain proteins that are coupled to G-proteins and signaled through intracellular cyclic adenosine monophosphate. Many structural features conserved in other G-protein coupled receptors (GPCRs) are found in the melanocortin receptors. There are five melanocortin receptor subtypes and each of the melanocortin receptor subtypes has a different pattern of tissue expression and has its own profile regarding the relative potency of different melanocortin peptides. alpha-, beta- and gamma-MSH and ACTH are known endogenous agonist ligands for the melanocortin receptors. Agouti and AgRP are the only known naturally occurring antagonists of the melanocortin receptors. We have examined the molecular basis of all five human melanocortin receptors for different ligand binding affinities and potencies using chimeric and mutated receptors. Our studies indicate that human melanocortin MC(1) receptor, human melanocortin MC(3) receptor, human melanocortin MC(4) receptor and human melanocortin MC(5) receptor utilize orthosteric sites for non selective agonists, alpha-MSH and NDP-alpha-MSH, high affinity binding and utilize allosteric sites for selective agonist or antagonist binding. Furthermore, our results indicate that molecular determinants of human melanocortin MC(2) receptor for ACTH binding and signaling are different from that of other melanocortin receptors. Many studies also indicate that agonists can induce different conformation changes of melanocortin receptors, which then lead to the activation of different signaling pathways, even when the expression level of receptor and the strength of stimulus-response coupling are the same. This finding may provide new information for the design of drugs for targeting melanocortin receptors. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:125 / 130
页数:6
相关论文
共 44 条
[1]  
Adan RAH, 1997, RECEPTOR CHANNEL, V5, P215
[2]   Drug target discovery by pharmacogenetics: mutations in the melanocortin system and eating disorders [J].
Adan, RAH ;
Vink, T .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2001, 11 (06) :483-490
[3]   Characterization of melanocortin receptor ligands on cloned brain melanocortin receptors and on grooming behavior in the rat [J].
Adan, RAH ;
Szklarczyk, AW ;
Oosterom, J ;
Brakkee, JH ;
Nijenhuis, WAJ ;
Schaaper, WMM ;
Meloen, RH ;
Gispen, WH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 378 (03) :249-258
[4]  
CHAI B, 2006, REGUL PEPT
[5]   Melanocortin-4 receptor-mediated inhibition of apoptosis in immortalized hypothalamic neurons via mitogen-activated protein kinase [J].
Chai, Biaoxin ;
Li, Ji-Yao ;
Zhang, Weizhen ;
Newman, Erika ;
Ammori, John ;
Mulholland, Michael W. .
PEPTIDES, 2006, 27 (11) :2846-2857
[6]   Melanocortin-4 receptor activation inhibits c-Jun N-terminal kinase activity and promotes insulin signaling [J].
Chai, Biaoxin ;
Li, Ji-Yao ;
Zhang, Weizhen ;
Wang, Hui ;
Mulholland, Michael W. .
PEPTIDES, 2009, 30 (06) :1098-1104
[7]   Role of the melanocortin-4 receptor in metabolic rate and food intake in mice [J].
Chen, AS ;
Metzger, JM ;
Trumbauer, ME ;
Guan, XM ;
Yu, H ;
Frazier, EG ;
Marsh, DJ ;
Forrest, MJ ;
Gopal-Truter, S ;
Fisher, J ;
Camacho, RE ;
Strack, AM ;
Mellin, TN ;
MacIntyre, DE ;
Chen, HY ;
Van der Ploeg, LHT .
TRANSGENIC RESEARCH, 2000, 9 (02) :145-154
[8]   Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass [J].
Chen, AS ;
Marsh, DJ ;
Trumbauer, ME ;
Frazier, EG ;
Guan, XM ;
Yu, H ;
Rosenblum, CI ;
Vongs, A ;
Feng, Y ;
Cao, LH ;
Metzger, JM ;
Strack, AM ;
Camacho, RE ;
Mellin, TN ;
Nunes, CN ;
Min, W ;
Fisher, J ;
Gopal-Truter, S ;
MacIntyre, DE ;
Chen, HY ;
Van der Ploeg, LHT .
NATURE GENETICS, 2000, 26 (01) :97-102
[9]   Discovery of 1-{2-[(1S)-(3-dimethylaminopropionyl)amino-2-methylpropyl]-4-methyl-phenyl}-4-[(2R)-methyl-3-(4-chlorophenyl)-propionyl]piperazine as an orally active antagonist of the melanocortin-4 receptor for the potential treatment of cachexia [J].
Chen, Chen ;
Jiang, Wanlong ;
Tucci, Fabio ;
Tran, Joe A. ;
Fleck, Beth A. ;
Hoare, Sam R. ;
Joppa, Margaret ;
Markison, Stacy ;
Wen, Jenny ;
Sai, Yang ;
Johns, Michael ;
Madan, Ajay ;
Chen, Takung ;
Chen, Caroline W. ;
Marinkovic, Dragan ;
Arellano, Melissa ;
Saunders, John ;
Foster, Alan C. .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (22) :5249-5252
[10]   Molecular characterization of human melanocortin-3 receptor ligand-receptor interaction [J].
Chen, M ;
Aprahamian, CJ ;
Celik, A ;
Georgeson, KE ;
Garvey, WT ;
Harmon, CM ;
Yang, YK .
BIOCHEMISTRY, 2006, 45 (04) :1128-1137